Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective
- PMID: 31100923
- PMCID: PMC6560445
- DOI: 10.3390/microorganisms7050140
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective
Abstract
Research in Chlamydia trachomatis and Chlamydia pneumoniae has gained new traction due to recent advances in molecular biology, namely the widespread use of the metagenomic analysis and the development of a stable genomic transformation system, resulting in a better understanding of Chlamydia pathogenesis. C. trachomatis, the leading cause of bacterial sexually transmitted diseases, is responsible of cervicitis and urethritis, and C. pneumoniae, a widespread respiratory pathogen, has long been associated with several chronic inflammatory diseases with great impact on public health. The present review summarizes the current evidence regarding the complex interplay between C. trachomatis and host defense factors in the genital micro-environment as well as the key findings in chronic inflammatory diseases associated to C. pneumoniae.
Keywords: Chlamydia pneumoniae; Chlamydia trachomatis; host-pathogen interaction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Selected Immunological Mediators and Cervical Microbial Signatures in Women with Chlamydia trachomatis Infection.mSystems. 2019 Jun 4;4(4):e00094-19. doi: 10.1128/mSystems.00094-19. mSystems. 2019. PMID: 31164450 Free PMC article.
-
Assessing the number of genital chlamydial infections in the United States.J Reprod Med. 1985 Mar;30(3 Suppl):269-72. J Reprod Med. 1985. PMID: 4020783
-
Chlamydia trachomatis infection in women.J Reprod Med. 1985 Mar;30(3 Suppl):273-8. J Reprod Med. 1985. PMID: 4020784
-
Recent advances in Chlamydia trachomatis.Eur J Epidemiol. 1985 Dec;1(4):235-56. doi: 10.1007/BF00237099. Eur J Epidemiol. 1985. PMID: 3915982 Review.
-
Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.Expert Rev Vaccines. 2018 Jan;17(1):57-69. doi: 10.1080/14760584.2018.1417044. Epub 2017 Dec 21. Expert Rev Vaccines. 2018. PMID: 29264970 Review.
Cited by
-
Infections at the nexus of metabolic-associated fatty liver disease.Arch Toxicol. 2021 Jul;95(7):2235-2253. doi: 10.1007/s00204-021-03069-1. Epub 2021 May 24. Arch Toxicol. 2021. PMID: 34027561 Free PMC article. Review.
-
Pathogenic and Protective Roles of Neutrophils in Chlamydia trachomatis Infection.Pathogens. 2025 Jan 23;14(2):112. doi: 10.3390/pathogens14020112. Pathogens. 2025. PMID: 40005489 Free PMC article. Review.
-
Towards a Deeper Understanding of Chlamydia trachomatis Pathogenetic Mechanisms: Editorial to the Special Issue "Chlamydia trachomatis Pathogenicity and Disease".Int J Mol Sci. 2022 Apr 1;23(7):3943. doi: 10.3390/ijms23073943. Int J Mol Sci. 2022. PMID: 35409301 Free PMC article.
-
One-year epidemiological patterns of respiratory pathogens across age, gender, and seasons in Chengdu during the post-COVID era.Sci Rep. 2025 Jan 2;15(1):357. doi: 10.1038/s41598-024-84586-8. Sci Rep. 2025. PMID: 39747544 Free PMC article.
-
Airway Epithelial Innate Immunity.Front Physiol. 2021 Nov 26;12:749077. doi: 10.3389/fphys.2021.749077. eCollection 2021. Front Physiol. 2021. PMID: 34899381 Free PMC article.
References
-
- Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Clarke I.N. Development of a transformation system for Chlamydia trachomatis: Restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011;7:e1002258. doi: 10.1371/journal.ppat.1002258. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases